Business Description

Clarivate PLC is a global information services and analytics company that provides subscription-based data, insights, and workflow solutions. Operating primarily across the Academia & Government, Intellectual Property, and Life Sciences & Healthcare sectors, the company serves universities, law firms, and corporations worldwide. Clarivate is highly distinctive for its proprietary, industry-standard databases, including the Web of Science, ProQuest, and Derwent Innovation.

Everything on Clarivate PLC

Revenue (FY2025) $2.46B
YoY growth -4.0%
Operating margin 2.9%
Direction
Gross margin 66.0%
Net margin -8.2%

Earnings Transcripts

View all transcripts ↗

Leadership & board

View leadership ↗
Andrew Snyder — Non-Executive Chair View full profile ↗ Jane Okun Bomba — Director View full profile ↗ Kenneth Cornick — Director View full profile ↗ Usama N. Cortas — Director View full profile ↗ Suzanne Heywood — Director View full profile ↗ Adam T. Levyn — Director View full profile ↗ Anthony Munk — Director View full profile ↗ Wendell Pritchett — Director View full profile ↗ Saurabh Saha — Director View full profile ↗ Matti Shem Tov — Chief Executive Officer View full profile ↗ Michael Easton — Executive Vice President & Chief Financial Officer View full profile ↗ Jonathan Collins — Executive Vice President and Chief Financial Officer View full profile ↗ William Graff — Executive Vice President, Chief Information Officer View full profile ↗ Henry Levy — President, Life Sciences & Healthcare View full profile ↗ Maroun Mourad — President, Intellectual Property View full profile ↗ Bar Veinstein — President, Academia & Government View full profile ↗ Gordon Samson — Former President, Intellectual Property View full profile ↗ Melanie Margolin — Former Executive Vice President and Chief Administrative and Legal Officer View full profile ↗ Simon Webster — President, Intellectual Property View full profile ↗ John Doulamis — Senior Vice President, General Counsel View full profile ↗

Share Repurchase Program

Total authorized
$500.0 million (December 2024 Board authorization); shareholders separately approved open-market purchases of up to 100 million ordinary shares through May 6, 2030 at $1-$35 per share (approved May 7, 2025)
Remaining (January 1, 2025 through December 31, 2026)
$276.0 million (as of December 31, 2025, under the $500 million program)
Latest FY repurchased
$224.5 million (FY2025; 56.0 million ordinary shares repurchased and retired)

Recent SEC Filings

2026-07-29 Leadership change (directors/officers) (+1 more) View filing ↗
2026-07-29 Reported quarterly results (+1 more) View filing ↗
2026-07-06 Entered a material agreement (+1 more) View filing ↗
2026-07-06 Regulation FD disclosure View filing ↗
2026-06-08 Leadership change (directors/officers) (+1 more) View filing ↗
2026-05-18 Shareholder vote results (+1 more) View filing ↗
2026-04-29 Reported quarterly results (+1 more) View filing ↗
2026-03-26 Leadership change (directors/officers) View filing ↗
2026-02-24 Reported quarterly results (+1 more) View filing ↗
2026-02-03 Regulation FD disclosure View filing ↗
2026-02-02 Terminated a material agreement (+1 more) View filing ↗
2025-10-29 Reported quarterly results (+1 more) View filing ↗

More Companies

See how Top Bucket AI works for your firm

Request Demo
Top Bucket AI Research

Stay ahead of private markets

Research and market intelligence for private-markets professionals.

You're subscribed.

Thanks for signing up.